2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

Special Lecture Monday, May 23, 2011, 1:30 PM – 4:00 PM • East Ballroom • Third Floor Robert Tigerstedt Award Lecture Oscar A. Carretero, MD, FASH Oscar A. Carretero, MD was born in Mendoza, Argentina and received his degree from the School of Medicine at the University of Cuyo, Mendoza, Argentina. Dr. Carretero has contributed greatly to our understanding of the role of vasoactive hormones in the regulation of blood pressure and renal function, as well as the pathogenesis of hypertension and target organ damage (TOD). His research has resulted in over 360 publications. His fundamental contributions began with his initial hypothesis in 1972 that renal kinins may be involved in the regulation of sodium and water excretion, acting as natriuretic and diuretic hormones. His work has contributed uniquely to the understanding of the role of the renal kallikrein-kinin system, ranging from the development of methods to measure the components of the system and its localization to demonstrating that the renal kallikrein-kinin system is natriuretic and diuretic not only in high mineralocorticoid situations but also in the basal state. This work culminated with the demonstration that animals lacking the main kinin receptor (B2) develop hypertension when they are fed a high sodium diet. As a pioneer in the field of kinin research, where his contributions have been fundamental, numerous, and of high quality, we now understand that kinins act as paracrine hormones, regulating organ blood flow and renal function, and also participate on the chronic cardiovascular protective effect of angiotensin-converting enzyme (ACE) and angiotensin resector blockers. He and his colleagues demonstrated that kallikrein in the kidney is produced mainly in the connecting tubule (CNT) and in collaboration with Luciano Barajas they demonstrated that the CNT returns to the glomerulus and makes contact with the afferent arteriole. Recently he demonstrated that there is a crosstalk between the CNT and the afferent arteriole, showing that when sodium is increased in the perfusate of the CNT, the afferent arteriole dilates. They call this cross talk between the CNT and the afferent arteriole connecting tubuloglomerular feedback. This seminal contribution explains why during a sodium load, renal blood flow increases. Recently he has made another seminal contribution by demonstrating that the endogenous tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (Ac-SDKP); that is destroyed mainly by ACE; has anti-inflammatory and anti-fibrotic effects, and also contributes to the cardiovascular and renal protective effect of ACE inhibitors. Furthermore, he discovered that the enzyme prolyl oligopeptidase is involved in the release of Ac-SDKP from the protein thymosin β-4. He has shown that inhibition of this enzyme promotes vascular and renal fibrosis. He and his group have demonstrated that this peptide inhibits fibrosis by a) decreasing inflammation, b) fibroblast proliferation and collagen synthesis, c) TGF expression and d) its TGF signaling (Smad phosphorylation). 20 continued…
Special Lecture continued In addition, Dr. Carretero has trained numerous investigators in the field of hypertension. Among his distinguished and well-known students are Alberto Nasjletti, Professor of Pharmacology at the Medical College of New York; A Guillermo Scicli, Professor of Medicine Henry Ford Health Sciences, Wayne State University; and Sadayoshi Ito, Chairman and Professor of Medicine, Tohoku University; Luis Juncos, Division Director, Nephrology, University of Mississippi. These are among many who have become important investigators in the field of cardiovascular or renal physiology and medicine. Dr. Carretero is an active invited international lecturer, and has received many awards including a Lifetime Achievement Award from the Inter- American Society of Hypertension and the Novartis award from the Council of High Blood Pressure Research, American Heart Association. He also received a Dr. Honoris Causa from University of Cordoba and a Professor Honoris Causa from the University of Mendoza. He has been Chairman, Council for High Blood Pressure Research of the AHA, and President of the Inter-American Society of Hypertension. He also serves in various NIH study sections and committees and serves on the editorial boards of several scientific journals. 21
Page 1 and 2: American Society of Hypertension, I
Page 3: Visit booth #1100 to find out more
Page 6 and 7: Past Presidents of the American Soc
Page 8 and 9: Program Color Key The pages of this
Page 10 and 11: Letter continued Following the Awar
Page 12 and 13: General Information continued Discl
Page 14 and 15: General Information continued ASH S
Page 16 and 17: General Information continued ASH P
Page 18 and 19: 2011 ASH Corporate Members Boehring
Page 20 and 21: ASH Leadership 2010-2011 Board of D
Page 24 and 25: Young Scholar Award* Monday, May 23
Page 26 and 27: Special Lecture Monday, May 23, 201
Page 28 and 29: 2011 Abstract Reviewers Lawrence J.
Page 30 and 31: More than half of hypertensive pati
Page 32 and 33: Poster Category Presentation Poster
Page 34 and 35: 2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37: 2011 ASH Faculty continued David L.
Page 38 and 39: American Society of Hypertension, I
Page 40 and 41: Program Color Key The pages of this
Page 42 and 43: MAY 21 Saturday Morning Hypertensio
Page 44 and 45: MAY 21 Sessions Saturday Afternoon
Page 50 and 51: MAY 21 Posters Saturday Evening Pos
Page 52 and 53: MAY 22 Sunday morning Sessions cont
Page 54 and 55: MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57: MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59: MAY 22 Debates Sunday Morning 11:00
Page 60 and 61: MAY 22 Plenary Session I Sunday Aft
Page 62 and 63: MAY 22 Special Sessions Sunday Afte
Page 64 and 65: MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67: MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69: MAY 23 Sessions Monday morning 8:00
Page 70 and 71: MAY 23 Sessions Monday morning 8:30
Page 72 and 73:
MAY 23 Sessions Monday morning 10:0
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
MAY 23 Plenary Session II Monday Af
Page 80 and 81:
MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83:
MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85:
MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88:
2011 American Society of Hypertensi
Page 89 and 90:
Saturday Afternoon MAY 21 Posters 4
Page 91 and 92:
Saturday Afternoon MAY 21 Posters P
Page 93 and 94:
Saturday Afternoon MAY 21 Posters E
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Saturday Afternoon MAY 21 Posters I
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Sunday Morning MAY 22 Posters 10:00
Page 109 and 110:
Sunday Morning MAY 22 Posters 10:00
Page 111 and 112:
Sunday Morning MAY 22 Posters PO-13
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Monday Morning Afternoon MAY 21 23
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Faculty Disclosure Listing Rajiv Ag
Page 149 and 150:
Faculty Disclosure Listing continue
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
ASH Hypertension Resource Pavilion
Page 159 and 160:
2011 ASH Innovations Theater Rhinel
Page 161 and 162:
2011 ASH Exhibitors continued A & D
Page 163 and 164:
2011 ASH Exhibitors continued David
Page 165 and 166:
2011 ASH Exhibitors continued Inter
Page 167 and 168:
2011 ASH Exhibitors continued Novar
Page 169 and 170:
2011 ASH Exhibitors continued Wiley
Page 171 and 172:
Author Index Berezina, Aelita V., 8
Page 173 and 174:
Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176:
Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178:
Author Index Makani, Harikrishna, 1
Page 179 and 180:
Author Index Rabelink, Ton J., 93 R
Page 181 and 182:
Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184:
Hilton New York Floor Plans Second
Page 185 and 186:
Hilton New York Floor Plans Fourth
Page 187 and 188:
Tekamlo (aliskiren and amlodipine)
Page 189 and 190:
25% (systolic) and 27% (diastolic)
Page 191 and 192:
Two cases of angioedema with respir
Page 193 and 194:
amlodipine and sildenafil were used
Page 195 and 196:
Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?